SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS)
IONS 74.30+0.2%Oct 31 9:30 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: bob zagorin5/27/2011 11:48:44 AM
   of 4676
 
COMPOUNDS AND METHODS FOR MODULATING PROTEIN EXPRESSION
United States Patent Application 20110124591
Kind Code A1
Bennett; C. Frank May 26, 2011

--------------------------------------------------------------------------------
COMPOUNDS AND METHODS FOR MODULATING PROTEIN EXPRESSION

Abstract
The present invention provides compounds and methods for modulating expression of a protein, including, but not limited to, modulating splicing of a pre-mRNA to modulate the amount of one or more variants of a protein.

--------------------------------------------------------------------------------
Inventors: Bennett; C. Frank; (Carlsbad, CA)
Assignee: ISIS Pharmaceuticals Inc.
Carlsbad
CA

Serial No.: 742652
Series Code: 12
Filed: November 13, 2008
PCT Filed: November 13, 2008
PCT NO: PCT/US08/83448
371 Date: October 8, 2010

Current U.S. Class: 514/43; 435/455
Class at Publication: 514/43; 435/455
International Class: A61K 31/7088 20060101 A61K031/7088; C12N 15/85 20060101 C12N015/85

BACKGROUND OF THE INVENTION

[0003] Antisense compounds have been used to modulate target nucleic acids. Antisense compounds comprising a variety of modifications and motifs have been reported. In certain instances, such compounds are useful as research tools and as therapeutic agents. In certain instances antisense compounds have been shown to modulate protein expression by altering splicing of a pre-mRNA, by arresting translation and/or by interrupting poly-adenylation of a pre-mRNA.

SUMMARY OF THE INVENTION

[0004] In certain embodiments, provided herein are compounds and methods that modulate protein expression, including, but not limited to, modulation of splicing.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext